New drug cocktail aims to make inoperable kidney tumors removable
Disease control
Recruiting now
This phase 2 trial is testing a combination of two drugs, zanzalintinib and nivolumab, given before surgery to people with advanced kidney cancer that is hard to remove. The goal is to shrink the tumor enough so that surgery becomes possible. About 69 participants will receive th…
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC